This announcement is a separate document:
方盛制药董事会审计委员会关于2023年度年审会计师履行监督职责情况的报告
Report of the Audit Committee of the Board of Directors of Fangsheng Pharmaceutical on the performance of supervisory duties by accountants in the 2023 annual audit
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.